Travel vaccines in demand
According to a new report from market researcher Technavio, the global travel vaccines market is expected to grow at a compound annual growth rate (CAGR) of around seven per cent during the forecast period of 2016-20.
The report classifies the market, based on disease type, into meningococcal vaccines, hepatitis B vaccines, hepatitis A vaccines, and others (which include vaccines of Japanese encephalitis, rabies, typhoid, yellow fever, and measles).
According to the report, globalisation is fuelling the demand for travel vaccines. It found that the Americas is the largest travel vaccines market, which had a share of more than 64 per cent in 2015. It also discovered that the travel vaccines market in the Americas is growing at a moderate rate, but slower than Europe, the Middle East and Africa (EMEA) and Asia-Pacific (APAC).
You can request a sample report here.